"FU-IFM2009" Database Post IFM/DFCI 2009 Study
NCT03679351 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 675
Last updated 2020-07-30
Summary
Extension of patient follow-up of the IFM/DFCI 2009 study over a period of 4 years (that is, from 01 December 2016 to 30 November 2020) during which patients will be followed up in the normal course of care and according to the usual care of the centers, with collection of the needed data about twice a year by the investigators
Conditions
Sponsors & Collaborators
-
University Hospital, Toulouse
lead OTHER
Principal Investigators
-
Michel Attal, MD PhD · University Hosptial toulouse
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-15
- Primary Completion
- 2020-11-30
- Completion
- 2020-11-30
Countries
- France
Study Locations
More Related Trials
-
Study on the Role of FDG-PET in Patients With FL at Time of Relapse/Progression
NCT03525665 ·Status: COMPLETED
-
Follow-up of Patients With Curative-intent Surgical Resection for NSCLC
NCT00199615 ·Status: COMPLETED ·Phase: NA
-
PLACE OF THE 18F-FDG-PET/CT IN THE DIAGNOSTIC WORKUP IN PATIENTS WITH CLASSICAL FEVER OF UNKNOWN ORIGIN (FUO)
NCT04851379 ·Status: COMPLETED
-
Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study
NCT00169598 ·Status: UNKNOWN ·Phase: NA
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma
NCT03051581 ·Status: UNKNOWN ·Phase: NA
-
Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy
NCT02317393 ·Status: COMPLETED ·Phase: PHASE2
-
Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study
NCT01284829 ·Status: COMPLETED ·Phase: NA
-
18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
NCT03741231 ·Status: COMPLETED
-
Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma
NCT03891914 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors
NCT00850278 ·Status: COMPLETED ·Phase: NA
-
Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT
NCT00534989 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH)
NCT02352064 ·Status: UNKNOWN ·Phase: NA
-
Detection and Characterization of Residual Masses in Lymphomas
NCT02300402 ·Status: COMPLETED
-
18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.
NCT06164561 ·Status: RECRUITING
-
Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCC
NCT04391348 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer
NCT00135161 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.
NCT00200668 ·Status: TERMINATED ·Phase: NA
-
Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma
NCT02286531 ·Status: COMPLETED ·Phase: NA
-
Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT
NCT01261585 ·Status: COMPLETED
-
The Role of 18F-FDG-PET for Staging and Prognostication
NCT04600804 ·Status: COMPLETED
-
18F-FDG Tomography and Labeled Leukocyte Scintigraphy
NCT05994768 ·Status: COMPLETED
-
Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer
NCT01501630 ·Status: COMPLETED
-
Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner
NCT05381077 ·Status: UNKNOWN ·Phase: NA
-
Modeling of the Response to Hypofractionated Stereotactic Pulmonary Irradiation
NCT03175861 ·Status: UNKNOWN
-
Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III
NCT00199654 ·Status: COMPLETED ·Phase: PHASE3